Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Seminars in Oncology
|
April 1, 1991
Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study
M Stahl, E Schmoll, H Becker, et al.
Onkologie
|
February 1, 1990
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer
E Heidemann, B Steinke, J Hartlapp, et al.
Onkologie
|
February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society
K Possinger, H Wagner, P Worst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2013
Metastatic breast cancer: are we treating the same patients as in the past?
M-P Ufen, C H Köhne, M Wischneswky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group
G Cocconi, D Cunningham, E Van Cutsem, et al.
The International Journal of Biological Markers
|
April 14, 2004
Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing
D Luftner, P Henschke, A Kafka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 1998
Dose-intensified weekly paclitaxel induces multiple nail disorders
D Lüftner, B Flath, C Akrivakis, et al.
European Journal of Medical Research
|
March 6, 1999
Oxidant-induced lung injury in anticancer therapy
T Beinert, D Binder, M Stuschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
V Heinemann, H Wilke, H G Mergenthaler, et al.
Journal of Cancer Research and Clinical Oncology
|
August 24, 2004
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
P Schmid, J Krocker, G Morack, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Seminars in Oncology
|
April 1, 1991
Lonidamine versus high-dose tamoxifen in progressive, advanced renal cell carcinoma: results of an ongoing randomized phase II study
M Stahl, E Schmoll, H Becker, et al.
Onkologie
|
February 1, 1990
Randomized clinical trial comparing mitoxantrone with epirubicin and with doxorubicin, each combined with cyclophosphamide in the first-line treatment of patients with metastatic breast cancer
E Heidemann, B Steinke, J Hartlapp, et al.
Onkologie
|
February 1, 1991
Oral administration of idarubicin as first line cytostatic therapy in patients with metastasized breast cancer and favourable prognosis. A trial of the phase II study group of the Association for Medical Oncology of the German Cancer Society
K Possinger, H Wagner, P Worst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2013
Metastatic breast cancer: are we treating the same patients as in the past?
M-P Ufen, C H Köhne, M Wischneswky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 17, 1998
Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group
G Cocconi, D Cunningham, E Van Cutsem, et al.
The International Journal of Biological Markers
|
April 14, 2004
Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing
D Luftner, P Henschke, A Kafka, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 3, 1998
Dose-intensified weekly paclitaxel induces multiple nail disorders
D Lüftner, B Flath, C Akrivakis, et al.
European Journal of Medical Research
|
March 6, 1999
Oxidant-induced lung injury in anticancer therapy
T Beinert, D Binder, M Stuschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
V Heinemann, H Wilke, H G Mergenthaler, et al.
Journal of Cancer Research and Clinical Oncology
|
August 24, 2004
Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
P Schmid, J Krocker, G Morack, et al.
Page
of 17